The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Earnings drive big swings in European stocks ahead of Fed

Wed, 29th Jul 2020 09:50

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)

* Investors await Fed, U.S. fiscal stimulus update

* Paris outperforms as Kering, Schneider earnings support

* Chemicals giant BASF slides as dividend under review
(Updates to market close)

By Sruthi Shankar

July 29 (Reuters) - Europe's main stocks benchmark closed
nearly flat on Wednesday, as investors waited to hear from the
U.S. Federal Reserve, but a flurry of earnings reports drove big
swings in individual stocks.

When the Fed concludes its monetary policy meeting later in
the day, investors are hoping that policymakers will reiterate
their accommodative stance to support financial markets as the
coronavirus pandemic takes its toll.

In a busy earnings day, the pan-European STOXX 600
closed down 0.1%, with healthcare and banks
dragging on the main index, while retailers jumped 1.4%.

Drugmaker GlaxoSmithKline fell 3.2% as it missed
second-quarter profit estimates after lower sales of its
existing vaccines, while lender Barclays dropped 6.1%
as it set aside a higher than expected 1.6 billion pounds ($2.1
billion) to cover a possible rise in loan losses due to the
pandemic.

The pair helped keep London's FTSE 100 nearly flat.

France's CAC 40 outperformed its continental peers
with a 0.6% rise after positive earnings updates from luxury
group Kering, electrical equipment group Schneider
Electric and consulting firm Capgemini.

"Markets have rallied aggressively, so what we're seeing is
companies coming with better numbers but not seeing an
additional uptick in markets," said Will James, deputy head of
European equities at Aberdeen Standard Investments.

"Companies that have managed earnings and sales, there have
been aggressive cost measures put in place."

Profits for STOXX 600 companies are expected to drop by a
record 59% in the second quarter, according to Refinitiv data.
But with much of the decline priced in, European stocks are on
course to end July with gains as investors bet on more stimulus.

Euro zone banks took a beating as Deutsche Bank
fell 2.5% after giving a slightly improved outlook
for the year, but chief executive Christian Sewing damped
speculation that the lender was eager to revive merger talks
with Commerzbank.

Spain's Santander slid 4.7% as it reported a record
net loss of 11.1 billion euros ($13 billion) in the second
quarter.

Chemicals giant BASF SE dropped 4.9% as it said
its dividend policy and the value of assets on its balance sheet
might be revised given uncertainty caused by the coronavirus
crisis.

UK retailer Next jumped 7.7% as it raised its profit
forecast after sales fell less than feared over the past three
months.
(Reporting by Sruthi Shankar in Bengaluru; Editing by Bernard
Orr and Uttaresh.V)

More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.